Darnytsia Held a Production Tour for the European Business Association

Pharmaceutical Company ‘Darnytsia’ held a production tour for representatives of the European Business Association under the Programme for Management Development Pre-MBA.

During the tour, the members of the European Business Association got acquainted with the business processes of Darnytsia and learned more about the company.

In particular, the tour participants were told that Darnytsia is the leader of the pharmaceutical market of Ukraine in terms of sales volume. Thus, as of the end of 2023, the market share of Darnytsia in volume terms was 15.77%. At the same time, the market share in monetary terms is 5.48%.

The production of Darnytsia meets the requirements of GMP (Good Manufacturing Practice).

Darnytsia medicinal products are represented in 16 countries of the world apart from Ukraine.

Darnytsia is a modern company that employs the latest technologies in its work, constantly confirming its digital leadership in the industry.

During the production tour, representatives of the European Business Association were introduced to the production facilities of Darnytsia and the use of advanced technologies in the production of medicinal products.

‘We are pleased to show our production and share progressive experience within the framework of cooperation with business associations. I am convinced that such knowledge will be useful and will contribute to the sustainable growth of the companies whose representatives visited our production facilities, despite the challenges of the full-scale war. Only by combining knowledge, effort, and experience, we can achieve more’, Serhii Bobylev, Compliance, Corporate & Legal Director at Pharmaceutical Company ‘Darnytsia’, said.

For their part, the representatives of the European Business Association thanked for the tour and the opportunity to get acquainted with good manufacturing practices in the production of domestic medicines in compliance with international standards.